SLC2A9 Gene Hypouricemia Renal Type 2 NGS Genetic DNA Test
Comprehensive Genetic Analysis for Renal Hypouricemia
The SLC2A9 Gene Hypouricemia Renal Type 2 NGS Genetic DNA Test represents a breakthrough in metabolic disorder diagnostics, offering precise identification of genetic mutations associated with renal hypouricemia type 2. This hereditary condition involves impaired uric acid reabsorption in the kidneys, leading to abnormally low serum uric acid levels and potential renal complications.
What This Advanced Test Detects
This sophisticated genetic screening utilizes Next-Generation Sequencing (NGS) technology to comprehensively analyze the SLC2A9 gene, which encodes the GLUT9 uric acid transporter protein. The test specifically identifies:
- Pathogenic mutations in the SLC2A9 gene sequence
- Variants affecting uric acid transport function
- Inheritance patterns of renal hypouricemia type 2
- Genetic markers associated with increased risk of exercise-induced acute kidney injury
- Mutations impacting renal urate handling and excretion
Who Should Consider This Genetic Screening
This test is particularly recommended for individuals experiencing:
- Unexplained persistently low serum uric acid levels (<2 mg/dL)
- Recurrent kidney stones despite normal uric acid metabolism
- Exercise-induced acute kidney injury episodes
- Family history of renal hypouricemia or related metabolic disorders
- Unexplained renal tubular dysfunction
- Children with developmental delays and metabolic abnormalities
- Individuals planning pregnancy with family history of metabolic disorders
Significant Benefits of Genetic Testing
Undergoing the SLC2A9 genetic test provides numerous advantages:
- Accurate Diagnosis: Confirms or rules out renal hypouricemia type 2 with high precision
- Personalized Treatment: Enables targeted management strategies based on genetic findings
- Family Planning Guidance: Provides crucial information for genetic counseling and reproductive decisions
- Preventive Measures: Helps implement lifestyle modifications to prevent exercise-induced complications
- Early Intervention: Facilitates proactive management before severe complications develop
- Comprehensive Understanding: Offers insights into the underlying cause of metabolic abnormalities
Understanding Your Test Results
Your genetic test results will be carefully interpreted by our expert genetic counselors and metabolic specialists:
- Positive Result: Indicates the presence of pathogenic SLC2A9 mutations, confirming renal hypouricemia type 2 diagnosis
- Negative Result: Suggests absence of known disease-causing mutations in the SLC2A9 gene
- Variant of Uncertain Significance: Identifies genetic changes whose clinical significance requires further investigation
- Carrier Status: Determines if you carry one copy of a mutated gene, which may be important for family planning
All results include detailed explanations and recommendations for next steps, including potential treatment options and lifestyle modifications.
Test Pricing and Availability
| Price Type | Amount (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
Nationwide Accessibility
We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network of certified genetic testing facilities ensures consistent quality and reliable results nationwide.
Take Control of Your Metabolic Health
Don’t let unexplained metabolic symptoms affect your quality of life. The SLC2A9 Gene Hypouricemia Renal Type 2 NGS Genetic DNA Test provides the clarity needed for proper diagnosis and management. Our team of genetic specialists is ready to guide you through the testing process and help interpret your results.
Ready to schedule your genetic screening? Contact our genetic counseling team today at +1(267) 388-9828 or book your appointment online. Take the first step toward understanding your genetic health and implementing effective management strategies for renal hypouricemia.
